Marksans Pharma rose 1.94% to Rs 315 after the company received final approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) , Loratadine Tablets.
Subscribe To Our Free Newsletter |
Marksans Pharma rose 1.94% to Rs 315 after the company received final approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) , Loratadine Tablets.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!